Goodwin Procter advised Ampersand Capital Partners on the deal. Ampersand Capital Partners announced its first and only closing of Ampersand 2022 Limited Partnership with $1.2 billion in...
You must be a Standard 1 Year member to access this content.
Goodwin advised Intermediate Capital Group on the deal. Intermediate Capital Group announced the structuring and fundraising of its eighth European Corporate fund. The Fund held a final...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Forge Global on the deal. Forge Global announced its definitive merger agreement with Motive Capital Corp (NYSE: MOTV.U) sponsored by affiliates of Motive Partners....
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised GeneWerk on the deal. GeneWerk announced its merger with Protagen Protein Services. GeneWerk, an Ampersand portfolio company, is a cell and gene therapy testing...
You must be a Standard 1 Year member to access this content.
